Target Entity: Medcuore Medical Solutions Private Ltd (MMSPL)
Type of Deal: Acquisition of minority stake through primary subscription of equity shares
Stake/Capacity: Additional 1.68% equity stake acquired, bringing total shareholding to 59.16% on a fully diluted basis. Number of shares acquired: 604 shares.
Funding Source: Not explicitly disclosed in the document
Financial Impact: Not explicitly disclosed in terms of revenue contribution, EBITDA impact, or accretion/dilution. The stated object is "to facilitate business growth and to generate revenue and to earn profit due to expansion of business."
Timeline: Indicative time period for completion of the acquisition is up to FY 2027-28
Strategic Rationale: To facilitate business growth, generate revenue, and earn profit through business expansion. MMSPL is engaged in the business of manufacturing, distribution and providing services in relation to Air Monitoring System and Air Purifiers.
Approval Status: No governmental or regulatory approvals required as per the disclosure
Reference Regulation: SEBI Regulation 30 read with Schedule III of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI master circular dated November 11, 2024 (SEBI/HO/CFD/PoD2/CIR/P/0155)
Additional Details:
Price per share: ₹16,536 (Rupees Sixteen thousand five hundred and thirty six)
Valuation: Based on valuation report issued by registered valuer
Not a related party transaction: None of the promoter/promoter group/group companies have any interest in MMSPL
